Showing results (141-150 of 181) with videos related to
Sort By:
Pageof 19
Human Psychopharmacology|January 26, 2017
Association study between the neurexin-1 gene and tardive dyskinesiaRachel Lanning, Tristram A Lett, Arun K Tiwari, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 1, 2010
The catechol-O-methyl-transferase gene in tardive dyskinesiaClement C Zai, Arun K Tiwari, Daniel J Müller, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2009
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesiaClement C Zai, Arun K Tiwari, Vincenzo De Luca, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2010
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in SchizophreniaArun K Tiwari, Clement C Zai, Olga Likhodi, et al.Journal of Psychiatric Research|September 11, 2013
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesiaClement C Zai, Arun K Tiwari, Marina Mazzoco, et al.Biological Psychiatry|April 10, 2018
A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in SchizophreniaVanessa F Gonçalves, Carolina Cappi, Christian M Hagen, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|October 25, 2022
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patientsUlker Isayeva, Mirko Manchia, Roberto Collu, et al.Neuroscience Letters|August 18, 2018
Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesiaJustin Y Lu, Arun K Tiwari, Gwyneth C Zai, et al.Frontiers in Pharmacology|December 19, 2019
Association Study of the Complement Component C4 Gene in Tardive DyskinesiaClement C Zai, Arun K Tiwari, Gwyneth C Zai, et al.Brain Sciences|December 23, 2022
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum DisordersMirko Manchia, Ulker Isayeva, Roberto Collu, et al.Pageof 19